As of 2025-09-14, the Relative Valuation of Ramm Pharma Corp (RAMM.CN) is (0.30) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.01 CAD, the upside of Ramm Pharma Corp based on Relative Valuation is -3056.2%.
The range of the Relative Valuation is (0.16) - (0.37) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 1.4x - 4.6x | 3.0x |
| Forward P/E multiples | 1.0x - 3.3x | 2.2x |
| Fair Price | (0.16) - (0.37) | (0.30) |
| Upside | -1684.3% - -3842.6% | -3056.2% |
| Date | P/E |
| 2025-09-04 | -0.09 |
| 2025-09-03 | -0.13 |
| 2025-09-02 | -0.13 |
| 2025-08-01 | -0.09 |
| 2025-07-30 | -0.09 |
| 2025-07-25 | -0.09 |
| 2025-07-24 | -0.13 |
| 2025-07-16 | -0.09 |
| 2025-07-07 | -0.09 |
| 2025-06-27 | -0.09 |